| Financial Year |
March 31 2023 |
| Monetary Funds |
338,512,496.58 |
| Held-for-trading Financial Assets |
400,459,017.62 |
| Notes Receivable |
30,674,769.36 |
| Accounts Receivable |
413,225,687.24 |
| Advances to Suppliers |
12,662,344.15 |
| Other Receivables |
9,417,350.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
394,297,763.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,304,810.30 |
| Total Current Assets |
1,707,802,851.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
50,119,081.94 |
| Investment Properties |
-- |
| Fixed Assetes |
350,378,970.42 |
| Under-construction Projects |
29,105,541.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,471,492.28 |
| R&D expenses |
-- |
| Goodwill |
97,417,831.64 |
| Long-Term Deferred and Prepaid Expenses |
2,354,847.85 |
| Deferred Income Tax Assets |
5,789,707.91 |
| Other Non-Current Assets |
1,880,222.91 |
| Sub-Total of Non-Current Assets |
624,383,486.63 |
| Total Assets |
2,332,186,337.86 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,937,886.07 |
| Accounts Payable |
198,064,600.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,528,630.85 |
| Taxes Payable |
25,832,178.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,788,051.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,853,039.30 |
| Other Current Liabilities |
8,281,471.52 |
| Sub-Total of Current Liabilities |
606,510,683.98 |
| Long-term Loans |
12,400,000.00 |
| Bonds Payable |
414,957,436.87 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,556,939.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
452,960,945.09 |
| Total Liabilities |
1,059,471,629.07 |
| Paid-In Capital(Or Share Stock) |
317,984,951.00 |
| Capital Surplus |
494,683,719.15 |
| Surplus Reserve |
64,130,825.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
374,304,364.95 |
| Minority Stockholder's Interest |
-153,659.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,272,868,368.59 |
| Owner's Equity（Stockholder's Equity） |
1,272,714,708.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,332,186,337.86 |
